Cost of Health Sharing with Chronic Illness (Realistic 10-Year Breakdown)

Health sharing with chronic conditions requires honest cost projections. See 10-year analyses for diabetes, hypertension, and asthma with real numbers.

Not sure which plans even cover your condition? Take our 60-second quiz to find plans that match your health situation. Then run your own long-term numbers with our cost projector tool — it factors in pre-existing condition waiting periods and annual contribution increases so you see the real picture.

You can also compare all plans side-by-side to see which ones have the shortest waiting periods for pre-existing conditions and the highest annual sharing limits.

Here is the thing nobody tells you up front: with a chronic condition, the headline monthly price is the least important number. What actually decides whether health sharing saves you money over ten years is the pre-existing waiting period — how long before your specific condition becomes eligible for sharing, and how much of it gets shared once the clock runs out. Get that part wrong and you can pay a low monthly contribution for years while still eating 100% of your condition's costs out of pocket. Get it right and you can genuinely save five figures over a decade.

Let's walk through it with real numbers from the plans we cover.

First, the honest part: health sharing is not insurance

Health sharing plans are membership organizations where members pool money to cover each other's large medical bills. They are not insurance, they are not regulated as insurance, and there is no legal guarantee that any given bill gets paid. Reputable plans have decades-long track records and pay reliably, but the structure is different from an ACA policy. For a chronic condition — something you'll be managing for years, not a one-time event — that difference matters more than it does for a healthy 28-year-old.

The single most important rule: anything you were diagnosed with or treated for before you joined is a pre-existing condition, and almost every plan limits or excludes it for a waiting period. The length of that waiting period, and what happens to your condition during it, is the whole ballgame.

The waiting-period table that actually matters

Here is how the plans we cover handle pre-existing conditions. These numbers come straight from each plan's published guidelines — read them carefully, because two plans with nearly identical monthly costs can be ten years apart in what they'll actually share for a chronic condition.

Notice the standout: Zion shares high blood pressure, high cholesterol, and type 2 diabetes from month one (as long as none of them put you in the hospital before you joined). Those three conditions account for an enormous share of all chronic-illness spending in the country. If your "chronic condition" is one of those three and well-controlled, Zion changes the entire ten-year math, because you skip the waiting period that hammers everyone else. We dig into the mechanics of this in our pre-existing conditions explainer.

Scenario 1: Type 2 diabetes, well-controlled, age 45

This is the most common chronic-illness situation we get asked about. You're managing type 2 diabetes with metformin and quarterly labs, your A1C is in range, and you've never been hospitalized for it. Annual medical reality: roughly $1,800–$3,000 a year in office visits, labs, and a generic medication, with the occasional flare pushing it higher.

The wrinkle: for diabetes, prescriptions and routine management are where the money goes, and that's exactly where health sharing is weakest. Most plans share large bills — a hospitalization, surgery, a serious complication — far better than they share the steady drip of maintenance meds and routine labs. KFF research on out-of-pocket diabetes costs shows the split between catastrophic and routine spending clearly — the routine portion is exactly what health sharing covers least. So you need to budget two things separately: your monthly contribution, and your out-of-pocket maintenance costs.

The takeaway: for a well-controlled type 2 diabetic, Zion is the rare plan where health sharing genuinely wins over a full decade, precisely because it skips the waiting period on this specific condition. With Medi-Share, the 36-month wait before pre-existing sharing starts means you carry all of the cost yourself in the early years, which eats into the savings — though it still likely beats an unsubsidized ACA plan over ten years. If you qualify for a large ACA subsidy, that math can flip entirely; we cover that tradeoff in our breakdown of health sharing versus traditional coverage.

Scenario 2: Hypertension, managed, age 50

High blood pressure controlled on a generic medication is close to the best-case chronic condition for health sharing. The medication is cheap (often $4–$15/month with a discount card), the monitoring is light, and the big risk — a cardiac event — is exactly the kind of catastrophic bill these plans are built to share.

Again, Zion stands out: hypertension is on its month-one list. So your "chronic condition" is effectively treated like any other member's health from day one, and a heart attack five years in would be a shareable need (subject to your IUA), not a pre-existing exclusion. Over ten years, a managed-hypertension member on Zion is paying roughly the contribution plus a modest med budget — call it $30,000–$36,000 across the decade if nothing major happens, with catastrophic protection if it does.

On a plan with a standard 12-month wait, you'd carry your own hypertension costs for that first year, but since those costs are small, the practical difference is minor — this is the one chronic condition where the waiting period barely stings. The catch is the cardiac-event scenario: if you have a heart attack in month 8 on a plan that treats your hypertension as pre-existing, the related cardiac care could be limited during the phase-in. That's the downside risk you're accepting in exchange for the lower price.

Scenario 3: Asthma, moderate, age 38

Asthma is the trickiest of the three because the cost is unpredictable and prescription-heavy. A controller inhaler can run $50–$300/month depending on the brand and whether a generic exists, and that's a recurring cost no health sharing plan reliably covers. The catastrophic risk — a severe attack landing you in the ER or ICU — is shareable on most plans, but only after the waiting period clears.

For a moderate asthmatic, the ten-year honest picture looks like this: your monthly contribution is low ($160–$280 depending on plan and age), but you should budget $1,200–$3,600/year in out-of-pocket inhaler and specialist costs that won't be shared. Over a decade that's $12,000–$36,000 in prescription spend alone, on top of contributions. Discount tools like GoodRx and manufacturer programs can cut that meaningfully, but you have to actively work them.

Who this is — and isn't — for

Health sharing can work well over 10 years if:

• Your condition is well-controlled hypertension, high cholesterol, or type 2 diabetes — especially with Zion, which shares these from month one
• Your main financial risk is a catastrophic complication (the thing these plans share best), not a steady stream of expensive maintenance meds
• Your medications are cheap generics, or you're disciplined about discount programs
• You don't qualify for a meaningful ACA subsidy (which would change the math against health sharing)

Stick with traditional insurance if:

• You depend on an expensive brand-name drug with no generic (insulin analogs, biologics, certain inhalers)
• Your condition requires frequent specialist visits, ongoing therapy, or regular procedures — the recurring, mid-size costs health sharing covers least well
• You're in active treatment right now for something serious — that's a pre-existing condition on day one and won't be shared during the waiting period
• You qualify for a large ACA subsidy that drops your premium below the health sharing contribution
• You need the legal guarantee of payment that only regulated insurance provides

The mistake that wrecks the 10-year math

The most expensive error we see: people pick the plan with the lowest monthly contribution without checking how their specific condition is treated during the waiting period. A plan that's $40/month cheaper but won't share your condition until year 4 can cost you tens of thousands if you have a complication in years 1–3. The cheap monthly number is a trap if the waiting period leaves your actual risk uncovered.

Run it the other way around. Start from your condition, find the plans that share it soonest, then compare price among those. For the big three (blood pressure, cholesterol, diabetes), that usually points to Zion. For other chronic conditions, you're comparing 12-month versus 24-month versus 36-month phase-ins, and the shorter one is almost always worth a higher monthly contribution.

Bottom line

For a well-controlled chronic condition — especially hypertension, high cholesterol, or type 2 diabetes — health sharing can save you $20,000–$30,000 over ten years versus an unsubsidized traditional plan, mostly because the contributions are dramatically lower and the catastrophic protection is real. The savings are largest on Zion, which shares those three conditions from month one and skips the waiting period that eats into everyone else's decade.

But the savings evaporate fast if your condition runs on expensive maintenance medications, needs frequent specialist care, or is currently in active treatment. In those cases the lower monthly price is a mirage — you'll pay the difference out of pocket, plus carry the risk of a denied or unshared need during the phase-in.

Do the boring work before you enroll: price your exact medications, confirm in writing how your specific condition is treated during the waiting period, and model the full ten years — not just month one. Take the quiz to narrow down plans that fit your condition, then run your own 10-year projection with your real numbers.

Affiliate Disclosure: WhichHealthShare may earn referral commissions from health sharing plans mentioned in this article. Commissions are paid by the plan and do not affect your pricing or our recommendations. Our editorial assessments are independent. See our full disclosure policy.

Last Updated: Feb 10, 2026